PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $591,106 | +49.0% | 35,438 | +146.6% | 0.02% | +53.3% |
| Q2 2023 | $396,844 | -74.5% | 14,368 | -78.8% | 0.02% | -76.9% |
| Q1 2023 | $1,557,100 | +246.8% | 67,700 | +27.3% | 0.06% | +261.1% |
| Q3 2022 | $449,000 | +10.9% | 53,190 | +3.8% | 0.02% | +5.9% |
| Q2 2022 | $405,000 | -51.1% | 51,264 | +46.5% | 0.02% | -52.8% |
| Q1 2022 | $829,000 | -34.7% | 35,000 | -5.7% | 0.04% | -55.0% |
| Q4 2021 | $1,269,000 | – | 37,100 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 750,632 | $7,724,000 | 26.59% |
| BVF INC/IL | 2,617,967 | $26,939,000 | 2.37% |
| GREAT POINT PARTNERS LLC | 982,449 | $10,109,000 | 1.58% |
| Alambic Investment Management, L.P. | 65,128 | $670,000 | 0.53% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,243,202 | $23,083,000 | 0.14% |
| ALGERT GLOBAL LLC | 44,477 | $458,000 | 0.10% |
| Monashee Investment Management LLC | 42,945 | $442,000 | 0.09% |
| Tekla Capital Management LLC | 219,042 | $2,254,000 | 0.08% |
| Spark Investment Management LLC | 138,800 | $1,428,000 | 0.08% |
| OXFORD ASSET MANAGEMENT LLP | 187,653 | $1,904,000 | 0.04% |